Ocular Therapeutix, Inc. (OCUL)
14.67
-0.74
(-4.80%)
USD |
NASDAQ |
Dec 11, 16:00
14.51
-0.16
(-1.09%)
After-Hours: 20:00
Ocular Therapeutix Profit Margin (Quarterly): -477.3% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Hologic, Inc. | 17.85% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
| Bristol Myers Squibb Co. | 17.96% |
| Krystal Biotech, Inc. | 81.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -83.37% |
| Return on Assets | -56.32% |
| Return on Invested Capital | -66.45% |
| Gross Profit Margin (Quarterly) | 87.80% |
| Operating Margin (Quarterly) | -472.3% |
| Return on Net Operating Assets | -498.2% |